Author name: Vincent Racaniello

I'm Professor of Microbiology and Immunology at Columbia University in New York. I run a research lab where we study poliovirus, rhinovirus, and other RNA viruses. I also love teaching about viruses - check out virology.ws, microbe.tv, or iTunes University for some of my offerings. I want to be Earth's virology professor.

Clinical benefit of lentiviral gene therapy in two patients with a rare neurologic disease

X-linked adrenoleukodystrophy (ALD) is a rare neurologic disease caused by a defect in a gene required for normal ABCD1 transporter function. The lack of this function leads to progressive demyelination, severe neurologic disease and death in males, often in childhood. ALD disease progression can be controlled by allogeneic hematopoietic cell transplantation (HCT) in those patients …

Clinical benefit of lentiviral gene therapy in two patients with a rare neurologic disease Read More »

The D225G change in 2009 H1N1 influenza virus is not a concern

The Norwegian Institute of Public Health recently identified a mutation in 2009 H1N1 influenza virus isolated from two patients who died and one with severe disease. It has been suggested that this mutation, which causes a change from the amino acid aspartic acid to glycine at position 225 of the viral HA protein (D225G), could …

The D225G change in 2009 H1N1 influenza virus is not a concern Read More »

TWiV 59: Dog bites virus

Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Gustavo Palacios, and Mady Hornig A TWiV panel of five considers the finding of Streptococcus pneumoniae in fatal H1N1 cases in Argentina, hysteria in the Ukraine over pandemic influenza, and human vaccinia infection after contact with a raccoon rabies vaccine bait. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV059.mp3″] Click the arrow above to …

TWiV 59: Dog bites virus Read More »

Raltegravir inhibits murine leukemia virus: implications for chronic fatigue syndrome?

The finding that a retrovirus, XMRV, is associated with chronic fatigue syndrome has lead to the suggestion that the disease might be treated with some of the antiviral drugs used to treat AIDS. The integrase inhibitor Raltegravir has been found to block the replication of murine leukemia virus, which is highly related to XMRV. But …

Raltegravir inhibits murine leukemia virus: implications for chronic fatigue syndrome? Read More »

Scroll to Top